Eastleigh Voice·58d ago
The weight-loss drug Wegovy has been approved in the UK for treating MASH-related liver fibrosis, a severe form of fatty liver disease characterized by excess fat accumulation in the liver, leading to inflammation and damage. This approval marks a significant development in addressing this health issue.